Adar1 Capital Management, LLC Portfolio Holdings

Adar1 Capital Management, LLC

  • $539 Billion
  • Q1 2025

Adar1 Capital Management, LLC has filed its 13F form on May 15, 2025 for Q1 2025 where it was disclosed a total value porftolio of $539 Billion distributed in 202 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Protagonist Therapeutics, Inc with a value of $45.4B, Ea Series Trust with a value of $37.6B, Roivant Sciences Ltd. with a value of $35.1B, Zai Lab LTD with a value of $34B, and Immunovant, Inc. with a value of $16.6B.

Examining the 13F form we can see an increase of $38.3B in the current position value, from $500B to 539B.

Adar1 Capital Management, LLC is based out at Austin, TX

Below you can find more details about Adar1 Capital Management, LLC portfolio as well as his latest detailed transactions.

Portfolio value $539 Billion
Healthcare: $348 Billion
ETFs: $21.5 Billion
Consumer Cyclical: $293 Million
Utilities: $103 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$2.45B
$45.4 Billion 8.44% of portfolio
939,669
Q1 2025 Reduced 7.91%
Ea Series Trust
-
$37.6 Billion 6.98% of portfolio
-
Q1 2025 Added 3.59%
$8.19B
$35.1 Billion 6.52% of portfolio
3,483,404
Q1 2025 Reduced 0.72%
$3.36B
$34 Billion 6.31% of portfolio
940,858
Q1 2025 Reduced 10.04%
$3.55B
$16.6 Billion 3.07% of portfolio
968,866
Q1 2025 Added 23.03%
$3.63B
$15.7 Billion 2.92% of portfolio
390,729
Q1 2025 Reduced 5.67%
$345M
$15.1 Billion 2.81% of portfolio
1,486,461
Q1 2025 Added 6,294.48%
Abivax Sa
-
$13.8 Billion 2.56% of portfolio
-
Q1 2025 Added 46.03%
$0
$12.4 Billion 2.31% of portfolio
135,585
Q1 2025 Added 2.88%
$7.07B
$11.7 Billion 2.18% of portfolio
339,635
Q1 2025 Reduced 49.97%
Inhibikase Therapeutics Inc
-
$11.2 Billion 2.08% of portfolio
-
Q1 2025 Added 0.37%
$2.93B
$9.17 Billion 1.7% of portfolio
207,778
Q1 2025 New
$0
$8.55 Billion 1.59% of portfolio
103,337
Q1 2025 New
$18.2B
$8.05 Billion 1.49% of portfolio
523,767
Q1 2025 Added 257.1%
$1.68B
$7.84 Billion 1.46% of portfolio
122,921
Q1 2025 Added 207.29%
Perceptive Cap Solutions Cor
-
$7.73 Billion 1.43% of portfolio
-
Q2 2024 New
$242M
$7.28 Billion 1.35% of portfolio
5,970,768
Q1 2025 Added 408.45%
$471M
$6.56 Billion 1.22% of portfolio
1,879,114
Q1 2025 Added 20.86%
$12.4B
$6.34 Billion 1.18% of portfolio
48,044
Q1 2025 New
$3.36B
$6.26 Billion 1.16% of portfolio
177,136
Q1 2025 Added 4.2%
Anteris Technologies Global
-
$6.11 Billion 1.13% of portfolio
-
Q1 2025 Added 59.37%
Aa Mission Acquisition Corp
-
$6.03 Billion 1.12% of portfolio
-
Q1 2025 Added 3.24%
$544M
$5.9 Billion 1.1% of portfolio
742,495
Q1 2025 Added 3,767.16%
$471M
$5.85 Billion 1.09% of portfolio
804,220
Q1 2025 Added 56.12%
Coherus Biosciences Inc
-
$5.48 Billion 1.02% of portfolio
-
Q4 2024 New
Oaktree Acquisition Corp Iii
-
$5.39 Billion 1.0% of portfolio
-
Q1 2025 Added 3.3%
Helix Acquisition Corp Ii
-
$5.31 Billion 0.99% of portfolio
-
Q1 2025 Added 16.23%
$369M
$5.21 Billion 0.97% of portfolio
1,471,587
Q1 2025 New
$1.74B
$5.05 Billion 0.94% of portfolio
157,079
Q1 2025 Added 705.33%
$2.03B
$4.28 Billion 0.79% of portfolio
127,548
Q1 2025 Added 152.34%
$528M
$4.24 Billion 0.79% of portfolio
398,152
Q1 2025 Added 69.71%
Mineralys Therapeutics Inc
-
$4.18 Billion 0.78% of portfolio
-
Q1 2025 Reduced 68.7%
$998M
$4.15 Billion 0.77% of portfolio
153,767
Q1 2025 Added 388.01%
Septerna Inc
-
$4.17 Billion 0.77% of portfolio
-
Q1 2025 New
Bridgebio Pharma Inc
-
$4.03 Billion 0.75% of portfolio
-
Q4 2024 New
Apogee Therapeutics Inc
-
$3.92 Billion 0.73% of portfolio
-
Q1 2025 Added 154.04%
$261M
$3.77 Billion 0.7% of portfolio
1,360,291
Q1 2025 Added 37.62%
$65.5M
$3.67 Billion 0.68% of portfolio
1,461,234
Q1 2025 Added 57.46%
Bioage Labs Inc
-
$3.65 Billion 0.68% of portfolio
-
Q1 2025 Added 689.27%
Monopar Therapeutics Inc
-
$3.67 Billion 0.68% of portfolio
-
Q1 2025 Reduced 22.5%
Zura Bio LTD
-
$3.61 Billion 0.67% of portfolio
-
Q1 2025 Added 34.85%
$97.3M
$3.43 Billion 0.64% of portfolio
641,690
Q1 2025 Added 605.28%
$193M
$3.24 Billion 0.6% of portfolio
1,116,047
Q1 2025 Reduced 17.89%
$1.28B
$3.11 Billion 0.58% of portfolio
216,166
Q1 2025 Added 40.34%
$2.39B
$2.88 Billion 0.53% of portfolio
71,143
Q1 2025 Added 364.77%
$2.55B
$2.82 Billion 0.52% of portfolio
66,960
Q1 2025 Reduced 17.8%
Bridgebio Pharma Inc
-
$2.74 Billion 0.51% of portfolio
-
Q1 2025 New
$376M
$2.51 Billion 0.47% of portfolio
350,352
Q1 2025 Added 105.93%
$3.54B
$2.55 Billion 0.47% of portfolio
50,023
Q1 2025 Added 4.16%

Summary

  • Portfolio
  • No. of Stocks 202
  • Current Value $539 Billion
  • Prior Value $500 Billion
  • Filing
  • Period Q1 2025
  • Filing Date May 15, 2025
  • Form Type 13F-HR
  • Activity in Q1 2025
  • New Purchases 47 stocks
  • Additional Purchases 68 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 40 stocks
Track This Portfolio

Track Adar1 Capital Management, LLC Portfolio

Follow Adar1 Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Adar1 Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Adar1 Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email